Atlas Trials

A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)

Clinical trial NCT03393975 · COMPLETED

Trial details

NCT number
NCT03393975
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Thrombotic Thrombocytopenic Purpura (TTP)
Start date
2017-10-13
Primary completion
2023-12-28
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.